News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Misako Nagasaka Shares FDA Approval of Taletrectinib for ROS1-Positive NSCLC
Misako Nagasaka/X
Jun 13, 2025, 07:19

Misako Nagasaka Shares FDA Approval of Taletrectinib for ROS1-Positive NSCLC

Misako Nagasaka, Thoracic Oncologist at University of California Irvine, posted on X:

“Another option for patients!!
On June 11, 2025, the FDA approved taletrectinib (Ibtrozi, Nuvation Bio Inc.), a kinase inhibitor, for adults with locally advanced or metastatic ROS1-positive NSCLC.”

More posts featuring NSCLC.

cancer FDA Misako Nagasaka NSCLC OncoDaily Oncology Taletrectinib
Special Coverage
Insight
Sep 9, 2025, 18:18
Debra Patt: The Augmented Oncologist
Positive
Sep 9, 2025, 18:07
Anirban Maitra: Meeting the New Medical Director of our Liver Cancer Program at NYU Langone Health
Voices
Sep 9, 2025, 17:59
Abstract Submission Is Open for ESTRO 2026
Blog Posts
Sep 9, 2025, 17:52
Celebrating All the Extraordinary Pediatric Oncology Nurses Around the World - Childhood Cancer International
Insight
Sep 9, 2025, 17:43
Jeremy Slone: 1995 Study on Pediatric Kaposi Sarcoma in Zambia
Voices
Sep 9, 2025, 17:28
Miguel Bronchud: Lancet Oncology Abstract on Calls to Reform Cancer MDTs in the English NHS
Insight
Sep 9, 2025, 17:15
EORTC Highlights New Research on Immunogenic Effects of Radiotherapy in Cancer Care
Blog Posts
Sep 9, 2025, 17:03
Brian Walusimbi: Grateful for Aladina Foundation's Love and Support in Uganda
Insight
Sep 9, 2025, 16:53
NIH Launches a New Initiative to Create a 21st Century Biosafety Framework
Blog Posts
Sep 9, 2025, 16:51
Thanking Stephen V Liu and the IASLC Staff at WCLC25
Insight
Sep 9, 2025, 16:45
Mulugeta Ayalew Yimer: Urgent Need for Practical Strategies to Reduce Treatment Abandonment for Children with Cancer
Insight
Sep 9, 2025, 15:59
Big News for MSS Colorectal Cancer - Fight Colorectal Cancer